Geneos Wealth Management’s Elbit Systems ESLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.1K Buy
28
+8
+40% +$6.08K ﹤0.01% 2126
2026
Q2
$15.2K Hold
20
– – ﹤0.01% 1891
2026
Q1
$17K Hold
20
– – ﹤0.01% 1831
2025
Q4
$11.6K Buy
+20
New +$10K ﹤0.01% 1921
2025
Q3
– Sell
-7
Closed -$3.15K – 2710
2025
Q2
$3.15K Hold
7
– – ﹤0.01% 2708
2025
Q1
$2.69K Buy
+7
New +$2.27K ﹤0.01% 2687
2022
Q2
– Sell
-11
Closed -$2K – 2648
2022
Q1
$2K Buy
+11
New +$2.08K ﹤0.01% 2537
2021
Q2
– Sell
-992
Closed -$135K – 2926
2021
Q1
$135K Buy
+992
New +$136K ﹤0.01% 1157
2017
Q3
– Sell
-27
Closed -$3K – 2122
2017
Q2
$3K Hold
27
– – ﹤0.01% 1843
2017
Q1
$3K Hold
27
– – ﹤0.01% 1803
2016
Q4
$2K Hold
27
– – ﹤0.01% 1843
2016
Q3
$2K Buy
27
+1
+4% +$97 ﹤0.01% 1768
2016
Q2
$2K Hold
26
– – ﹤0.01% 1671
2016
Q1
$2K Buy
+26
New +$2.23K ﹤0.01% 1653

Other funds holding ESLT

Geneos Wealth Management's ESLT Position: Q3 2026 in Review

Geneos Wealth Management increased its Elbit Systems (ESLT) stake by 40% in Q3 2026, buying an estimated $6.08K and bringing the position to 28 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

Geneos Wealth Management first reported a position in ESLT in Q1 2016 and has held it in 14 quarters since. The position peaked at $135K in Q1 2021. 210 funds tracked by Wall St. Rank hold ESLT as of Q3 2026.

  • Geneos Wealth Management held 28 shares of Elbit Systems worth $19.1K as of Q3 2026.
  • Geneos Wealth Management bought 8 Elbit Systems shares in Q3 2026, an estimated $6.08K.
  • Elbit Systems made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2126 holding.
  • Geneos Wealth Management first reported a position in Elbit Systems in Q1 2016 and has held it in 14 quarters since.
  • Geneos Wealth Management's Elbit Systems position peaked at $135K in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Elbit Systems as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.